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Abstract 
Purpose: To assess the sensitivity and responsiveness of HUI2 and HUI3 among Type 2 diabetes 
patients.  
Methods: This cross-sectional study was conducted in two purposively selected Nigerian tertiary 
hospitals. Six hundred and thirty-eight (638) adult patients were surveyed following their consent using 
the HUI2 and HUI3 (HUI23S4En.40Q) questionnaire. Patients’ clinical characteristics such as age, co-
morbidity, severity of disease, and utilization of hospital resources were postulated a priori to be 
associated significantly with utility scores of HUI2 and HUI3. Student’s t-test and bivariate analyses 
were conducted to determine the diabetes-severity discriminatory ability of HUI2 and HUI3. The 
analyses were conducted with SPSS 14.0. A two-tailed significance level of 0.05 was used. 
Results: Older patients had lower quality of life than younger patients. The overall health deficit of 
increasing age for HU13 was -0.2950 and that of overall HUI2 was -0.1553. The respondents without 
eye problem had higher quality of life than those with eye problem, in both HUI3 and HUI2 utility scores. 
Stroke was the most important patients’ characteristic that negatively affected HRQOL. Patients with 
duration of diabetes > 4 years had lower quality of life scores than their counterparts (≤ 4years).  
Conclusion: Health Utility Index Mark 2 and Mark 3 were sufficiently sensitive and responsive to 
diabetes severity among Type 2 diabetes patients. 
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Health utility index mark 2 and mark 3 have been 
used to assess HRQOL of diabetes patients [1]. 
Both the HUI2 and HUI3 contain attributes that 
would likely be affected by diabetes and diabetes 
complications. For instance diabetic complica-
tions such as peripheral neuropathy would 
presumably affect the mobility and self care 
attribute of the HU12 and the ambulation and 
dexterity attributes of the HUI3. Neuropathy and 
myopathy would likely affect the pain and 
discomfort attribute of the HUI2 and HUI3 and 
the dexterity attribute of the HU13. Finally, 
retinopathy would likely affect the vision attribute 
of the HUI3 and the sensation attribute of the 
HUI2 [2]. Evidence of construct validity of the 
health utilities index mark 2 (HUI) and mark 3 
(HUI3) in Type 2 diabetes [1,3], stroke and 
arthritis [4] had been generated in clinical 
samples. Thus, the HUI2 and HUI3 would be a 
reasonable choice of HRQOL measures for 
evaluating the impact of socio-demographics, co-
morbid medical conditions and resource 
utilization on HRQOL in diabetes patients.  
 
Health Utility Index (HUI) currently consists of 
two systems, HUI2 and HUI3, which together 
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describe almost 1,000,000 unique health states 
[4]. The two systems are independent but 
complementary. There is a growing trend for the 
use of HUI as a primary health outcome measure 
in the form of Quality Adjusted Life Years 
(QALYs) [5]. In diabetes, disease specific 
measures fail to capture the additional HRQOL 
deficits associated with co-morbidities that 
contribute to the disease burden [6]. Overall 
utility scores on the HUI2 can range from –0.03 
to 1.0, with –0.03 representing the utility of the 
worst possible HUI2 health state, 0.0 
representing dead, and 1.0 representing perfect 
health. Overall scores on the HUI3 can range 
from –0.36 to 1.0, with –0.36 representing the 
utility of the worst possible HUI3 health state (all 
attributes at the lowest level), 0.0 representing 
dead, and 1.0 representing perfect health [6]. For 
both instruments, differences of ≥ 0.03 on the 
overall scores and 0.05 or greater on the single 
attributes are considered to be clinically 
important. It is important to note, however, that 
differences in the content of overlapping 
attributes of the HUI2 and HUI3 may affect the 
performance of either instrument in Type 2 
diabetes. Pain and emotion are likely to be 
affected by the severity of diabetes. The pain and 
discomfort attribute of the HUI2 is focused on the 
alleviation of pain through medication, whereas 
the pain attribute of the HUI3 is more focused on 
the degree of disruption of activities. The emotion 
attribute of the HUI2 focuses on worry and 
anxiety, whereas the emotion attribute of the 
HUI3 specifically assesses happiness versus 
depression. It is not clear which content would 
better reflect the pain and emotional deficits 
associated with diabetes. Overall, though, the 
HUI3 is less subject to floor effects than the HUI2 
[4, 5, 6, 7, 8].  
 
Sensitivity (also called the true positive rate) 
measures the proportion of actual positives 
which are correctly identified as such (e.g. the 
percentage of sick people who are correctly 
identified as having the condition). The ability of 
HUI2 &3 to discriminate patients with multiple or 
severe illnesses that affect QoL in diabetes 
patients has been documented [3]. For 
questionnaires to provide useful measures of 
clinical outcome they need to demonstrate 
adequate clinimetric properties. One of the most 
important clinimetric properties of a questionnaire 
is responsiveness, which is defined as the ability 
of an outcome measure to detect true change 
over time [9]. There are two main approaches to 
quantifying responsiveness: anchor-based 
(external responsiveness) and distribution- based 
methods (internal responsiveness) [10].  
The aim of this study was to assess the 
sensitivity and responsiveness of HUI2 and HUI3 




Study design and area 
 
This cross-sectional study was conducted in two 
purposively selected Nigerian tertiary hospitals. 
The hospitals were University of Nigeria 
Teaching Hospital, Ituku Ozalla (UNTH), and 
Nnamdi Azikiwe University Teaching Hospital, 
Nnewi (NAUTH). UNTH began early in the 20th 
century as a standard general Hospital for 
Africans built by the colonial administrators.  It 
later metamorphosed into a general hospital on 
the attainment of Nigeria’s independence in the 
1960’s. However, at the end of the Nigerian civil 
war in 1970, the then government of East Central 
State transformed it into a Specialist Hospital 
with effect from July 1, 1970. At this time, the 
hospital had a total of 50 doctors, 10 wards, and 
300 beds and a chest bay of 60 beds.  There 
were also 350 nurses working in the Hospital.    
 
Today, the situation has changed dramati-
cally.  The bed capacity of the hospital in the 
permanent site is over 500 beds and the number 
of its personnel (professional and non – 
professional) has increased tremendously. The 
University of Nigeria Teaching Hospital became 
independent in July 1976 with the appointment of 
autonomous Management Board. 
 
Altogether, there are 41 main departments in the 
hospital with three out – posts – Comprehensive 
Health Centers at Obukpa near Nsukka, Enugu 
State, Abagana in Njikoka Local Government 
Area of Anambra State and Isuochi in Abia State. 
There are nine training schools/programmes in 
the hospital viz:  the School of Nursing, 
Midwifery, Medical Laboratory Science, Nurse 
Anesthetists, Community Health and Post 
Ophthalmic Nursing.  Others are Peri–Operative 
Nursing, Cardiothoracic Nursing and Medical 
Records. These schools currently operate at the 
old site but plans are already on the ground to 
provide structures for them in the New Site as 
soon as possible. It is also worthy to mention that 
Community services rendered by University of 
Nigeria  Teaching Hospital extend to various 
states in the country particularly those in the 
South–East Geopolitical zones. 
 
The Nnamdi Azikiwe Teaching Hospital Nnewi 
was established by the Anambra State of Nigeria 
(ASN) edict No 10 of 1988. The hospital was 
commissioned on Friday 19th July, 1991. 
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The Nnamdi Azikiwe Teaching Hospital therefore 
is a multi-campus complex comprising of the 
Main Hospital at Nnewi, the Diagnostic/Primary 
Health Care Centre at Nneni and Guiness Eye 
Hospital Onitsha. The location of the Main 
Teaching Hospital at Nnewi is temporary. It is 
hoped that in future, the hospital will move over 
to its permanent site at Okofia Nnewi. 
 
The Nnamdi Azikiwe Teaching Hospital Nnewi is 
a tertiary health institution which was set up to 
provide the students of the college of Health 
Sciences, Nnamdi Azikiwe University Nnewi the 
facilities for clinical training. It also aims at 
providing specialized medical attention/treatment 
to the citizens of Anambra State in particular and 
Nigeria in general. In addition to out-patient 
services, the Teaching Hospital also provides 
services and training in specialty areas such as 
Internal Medicine, Obsterics and Gynaecology, 
Paediatrics, and Surgery (Orthopaedic, Dental, 
Ophthalmic and General Surgery).  
 
The main branch of the Teaching Hospital has a 
bed capacity of two hundred (200). Since the 
conversion to a teaching hospital the staff 





Six hundred and thirty-eight (638) adult patients 
attending outpatient clinics of the hospitals that 
satisfied the inclusion criteria were surveyed 
following their oral consent. Inclusion criteria 
were: 18 years and above, diagnosed Type 2 
diabetes of at least one year, understanding of 
English Language, and not too ill to answer the 
questions. Investigators briefed the respondents 
on the purpose of the study and oral consent was 




Ethical clearances with reference numbers: 
UNTH/CSA.329/Vol.6 and NAUTH/CS/66/VOL. 
4/124 were obtained from UNTH and NAUTH 
respectively. Confidentiality and anonymity of the 
patients’ information were maintained throughout 
the study. This complete set of HUI23S4En.40Q 
instruments used in study were fully licensed and 




Administration and retrieval of (HUI23S4En.40Q) 
questionnaire was continuous for six weeks in 
each of the hospitals. The study was conducted 
from November 2010 to March 2011.  
Socio-demographic and clinical characteristics of 
the patients were obtained using another data 
collection form. Data obtained were on age, sex, 
marital status, occupational status, highest level 
of education, and smoking status. Self reported 
clinical characteristics were duration of diabetes, 
mode of glycemic control (e.g., oral medication, 
insulin and diet), utilization of hospital resources 
(e.g. overnight hospitalization in the past one 
year, emergency room visit and number of 
absenteeism from work in the past 6 months), 
and co-morbidities (e.g., hypertension, eye 
problem, stroke, depression and heart diseases).  
 
Analysis of data 
 
The derivation of health status classification 
levels, health states, single-attribute level utility 
scores and overall health-related quality of life for 
HUI2 and HUI3 were performed according to the 
algorithm presented in procedure of the manual 
(HUI23-40Q.MNL). In order to determine the 
diabetes-severity discriminatory ability of HUI2 
and HUI3, some hypotheses were postulated a 
priori, based on their relevance to diabetes and 
their ability to test the performance of the overall 
scores of HUI2 and HUI3. Demographic data 
(increasing age), co-morbidity (stroke; heart 
disease: hypertension, coronary heart diseases, 
congestive heart failure; eye problem and 
additional number of medical conditions > 1), 
severity of disease (use of insulin, use of oral 
medication, longer duration of diabetes and 
greater number of absenteeism from work in 
previous 6 months), and utilization of hospital 
resources (overnight hospitalization, more 
contact with physician in emergency room and 
physician visit) were postulated to be associated 
with significant health related quality of life 
(HRQOL) deficits [1-3, 11]. These were stratified 
using dichotomous events - ‘respondents with 
characteristics in question – Yes’ and 
‘respondents without the characteristics – No’. 
Two-sample comparisons were made using 
Student’s t-test for normally distributed variables 
or Mann–Whitney U-tests for non-normally 
distributed data, to determine the ability of each 
instrument to discriminate between ‘Yes’ and ‘No’ 
responses, as specified in the a priori hypothesis.  
Bivariate analysis was conducted to examine the 
specific effects of patients’ characteristics on 
single attributes of HUI2 and HUI3. Data analysis 
was conducted with SPSS 14.0® (Chicago, 
Illinois, USA). A two-tailed significance level of 




The results generally revealed that the studied 
population was mostly female, middle-aged, 
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moderately educated, mostly self-employed and 
many of the diabetes patients had heart-related 
diseases, (Table 1). Increasing age was 
significantly associated with HUI2 single 
attributes deficits in sensation (r = -0.364; p < 
0.01), mobility (r = -0.265; p < 0.01), self-care (r 
= -0.179; p < 0.05), cognition (r = -0.203; p < 
0.01) and pain (r = -0.212; p< 0.01), (Table 2). In 
HUI3 single attributes, increasing age also 
significantly affected vision (r = -0.315; p < 0.01), 
cognition (r = -0.245; p < 0.01), ambulation (r = -
0.274; p < 0.01) and pain (r = -0.192; p < 0.01). 
These deficits were both statistically and 
clinically significant. The HRQOL deficits 
imposed by increasing age were more on HUI2 
than HUI3 (Tables 2 and 3).  
 
Having eye problems significantly affected HUI2 
single attributes deficits in sensation (r -0.270; 
P< 0.01), mobility (r = -0.336; p < 0.01), self-care 
(r = -0.281; p < 0.01), cognition (r = -0.310; P< 
0.01) and pain (r = -0.375; p < 0.01), Table 2. In 
HUI3 single attributes, having eye problems was 
also significantly affected vision (r = -0.383; p < 
0.01), speech (r = -0.230; p < 0.01), dexterity (r = 
-0.300; p < 0.01) cognition (r = -0.312; p < 0.01), 
ambulation (r = -0.320; p < 0.01) and pain (r = -
0.353; p< 0.01). The health deficit for HUI3 was -
0.3589 while HUI2 deficit was -0.2100, (Table 2). 
The trends in the ‘having eye problems’ were the 
same as that of age, but eye problem was 
apparently more disabling than age as it had high 
negatively correlates with utility scores in both 
HUI2 and HUI3 (Table 4). The effect of eye 
problems was more on HUI3 than HUI2.  
 
Heart diseases significantly affected two HUI2 
single attributes in sensation (r = -0.208; p< 
0.01), and self-care (r = -0.157; p < 0.05), Table 
3. In HUI3 single attributes, heart diseases also 
significantly affected vision (r = -0.174; p < 0.05), 
emotion (r = -0.144; p < 0.05), ambulation (r = -
0.228; p < 0.05) and pain (r = -0.216; p < 0.05).  
Stroke significantly affected HUI2 single 
attributes deficits in sensation (r = -0.142; p< 
0.05), mobility (r = -0.467; p < 0.01), self-care (r 
= -0.606; p < 0.01), cognition (r = -0.487; p< 
0.01) and pain (r = -0.557; p < 0.01), Table 2. In 
HUI3 single attributes, stroke significantly 
affected vision (r = -0.155; p < 0.05), speech (r = 
-0.505; p < 0.01), dexterity (r = -0.472; p < 0.01), 
emotion (r = -0.209; p < 0.01) cognition (r = -
0.392; p < 0.01), ambulation (r = -0.505; p < 
0.01) and pain (r = -0.537; p < 0.01).  
 
Those respondents that had absenteeism of > 6 
days in the previous 6 months had lower utility 
scores than those that had ≤ 6 days absenteeism 
from work. Patients that had overnight 
hospitalization, more contact with physician or 
nurse in emergency room (ER), and those that 
visited their physicians more often ( > 12 times) 
in the previous 12 months had lower overall 
health utilities scores and single attributes utility 
scores in both HU13 and HU12. Visiting 
physicians for more 12 times affected all the 
HUI2 single attributes and 5 of 8 HUI3 single 
attributes; Emergency room contact affected 4 of 
6 HUI2 and 6 of 8 HUI3 single attributes 
significantly. The HUI2 and HUI3 instruments 
could capture, identify and discriminate this 
group of patients who used more of the hospital 
resources (Table 2-4).  
 
The instruments discriminated the quality of life 
of patients in different age groups, duration of 
diabetes, severity of diabetes, co-morbidity, and 




The HUI2 and HUI3 were able to capture 
debilitating effect of age on respondents by 
differentiating health deficits associated with 
young and old with greater deficits placed on the 
elderly. The older patients had lower quality of 
life than those of younger patients. This result is 
consistent with other studies conducted by Eljedi 
et al [12] in Gaza strip camp and Issa et al [13] in 
Nigeria, which showed that being old was 
associated with lower quality of life.  
 
The instruments were able to detect the 
similarities and differences in the interrelated and 
overlapping attributes in each of the instruments, 
this trend was similar all the patients’ 
characteristics examined. They captured the 
differences in the health deficits associated with 
having an eye problem and without. This is 
consistent with a study performed in Canada [14] 
which concluded that, the illness burden 
experienced by individuals with diabetes is not 
only associated with diabetes itself, but largely 
with co-morbid medical conditions. This eye 
problem could be attributed to diabetic 
retinopathy, which is a complication of diabetes.  
 
Identification of higher burdens (health deficits) in 
patients with heart diseases than those patients 
without heart diseases shows that heart disease 
is a common co-morbidity associated with 
diabetes. This is in accordance with a study 
which demonstrated that diabetes patients are 2 
to 4 times more likely to develop cardiovascular 
disease than those without diabetes [15]. This 
conforms to a study that found out that the 
presence of cardiovascular complications as co-
morbidities with diabetes led to deficit in health 
related quality of life [16].   
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Table 1: Characteristics of the patients  
 
Demographic data N = 638 
Age – mean (SD) 51.70 (6.81) 
Age (years)  % 
≤ 52 31.50 
> 52 68.50 
Sex (%) Male  45.00 
Level of education  % 
No formal education 26.00 
Primary school 28.00 
Secondary school 27.50 
University  18.50 
Marital status  % 
Currently married 60.00 
Widowed 25.00 
Separated 6.00 
Single  9.00 
Occupation  % 
Student 4.00 




Number of absenteeism from school/work in last 6 months (if not retired)_mean 
(SD) 
6.20 (2.53) 
number of absenteeism (days) % 
≤ 6 52.90 
> 6 47.10 
Smoking status % 
Current smoker 23.50 
Non – smoker 76.50 
Duration  of diabetes (years) – mean (SD) 4.30 (1.87) 
Duration of diabetes (years) % 
≤ 4 59.30 
> 4 40.70 
Family history of diabetes (%)- Yes 47.50 
Number of medical conditions_ mean (SD) 1.90 (0.76) 
Number of additional medical condition % 
 =1 59.30 
> 1 40.70 
Has eye problem (%) Yes 47.50 
Suffers the effect of stroke (%) Yes  14.50 
Has heart disease (%) Yes  85.50 
Overnight hospitalization (%) Yes 51.50 
Contact with physician or nurse in ER (%) Yes 17.00 
Number of physician visits in previous 12 months – mean (SD)  11.62 (4.76) 
Physician visits % 
≤ 12 59.30 
> 12 40.70 
Use of insulin (%) yes 47.50 
Use of medication (%) Yes 95.00 
Self-rated health  % 
Excellent  7.00 
Very good 20.00 
Good 30.00 
Fair 27.00 
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Table 2: Impact of patients’ characteristics on single attributes of HUI2 (Bivariant correlation) 
 Patients’ characteristics Siga Sensation Mobility Self care Emotion  Cognition  Pain 
Medication use 1 -0.167* -0.126 -0.088 -0.125 -0.131 -0.137 
Smoking status -Yes 1 -0.115 -0.115 -0.162* 0.090 -0.112 -0.127 
Has heart disease 2 -0.208** -0.105 -0.157* 0.085 -0.132 -0.099 
Overnight hospitalization 4 -0.144* -0.191** -0.008 0.096 -0.229** -0.207** 
Contact  with physician in ER 4 -0.132 -0.321** -0.165* 0.075 -0.389** -0.322** 
Use of insulin 4 -0.162* -0.230** -0.093 0.400 -0.219** -0.347** 
Stroke 5 -0.142* -0.467** -0.606** -0.059 -0.487** -0.557** 
Eye problem 5 -0.270** -0.336** -0.281** -0.050 -0.310** -0.375** 
Age > 52 years 5 -0.364** -0.265** -0.179* 0.021 -0.203** -0.212** 
medical condition >1 5 -0.283** -0.331** -0.242** 0.019 -0.281** -0.366** 
Duration of diabetes > 4 years 5 -0.246** -0.318** -0.198** -0.037 -0.360** -0.193** 
Physician visit > 12  6 -0.251** -0.204** -0.208** 0.152* -0.302** -0.413** 
*p < 0.05; ** p < 0.01; Siga = Number of single attributes out of 6 attributes that were significantly correlated with specific 
patients’ characteristics in increasing order. 
 
Table 3: Impact of patients’ characteristics on single attributes of HUI3 (bivariant correlation)  
 
Parameter Siga Vision Hearing  Speech Dexterity Emotion  Cognition  Ambulation Pain 
Smoking status -Yes 1 -0.121 0.082 -0.152* -0.056 0.071 -0.123 -0.124 -0.113 





-0.063 -0.108 -0.210** -0.041 -0.091 -0.178* -0.210** -0.189* 
Age > 52 years 4 -0.315** -0.126 -0.129 -0.132 -0.126 -0.245** -0.274** -0.192** 
Has heart disease 4 -0.174* 0.033 -0.128 -0.035 -0.144* -0.116 -0.228* -0.216* 
Physician visit > 12  5 -0.096 -0.105 -0.144* -0.222* 0.047 -0.302** -0.254** -0.380** 
Use of insulin 5 -0.076 -0.059 -0.194** -0.217** 0.056 -0.240** -0.263** -0.340** 
Contact  with 
physician in ER 
6 -0.067 -0.084 -0.314** -0.231** -0.143* -0.336** -0.314** -0.278** 
Eye problem 6 -0.383** 0.019 -0.230** -0.300** -0.134 -0.312** -0.320** -0.353** 
medical condition >1 6 
 
-0.151* -0.013 -0.153* -0.206** -0.095 -0.210** -0.377** -0.312** 
Duration of diabetes 
> 4 years 
6 -0.252** -0.109 -0.346** -0.192** -0.120 -0.372** -0.346** -0.397** 
Stroke 7 -0.155* -0.117 -0.505** -0.472** -0.209** -0.392** -0.505** -0.537** 
*p < 0.05; ** p < 0.01; Siga = number of single attributes out of 8 attributes that were negatively correlated with specific patients’ 
characteristics in increasing order 
 
The high negative correlates of stroke with utility 
scores were prominent in both HUI2 and HUI3  
single attributes, with self-care single attribute 
mostly affected in HUI2 and pain in HUI3. The 
instruments ability to capture these deficits 
associated with stroke is in agreement with other 
previous studies [17,18]. 
 
Having more than one medical condition to 
diabetes followed the same trends of ‘having 
heart diseases’, this similarity might be due the 
fact that most of the additional medical conditions 
were heart related diseases. HUI2 and HUI3 
were able to capture this similarity and it 
differentiated the patients with co-morbidity from 
those without. This conforms to study by 
Maddigan et al [19] which concluded that social 
and environmental factors are important 
determinants of health of health of diabetes 
patients, but co-morbidities have the largest 
impact on HRQOL among people with Type 2 
diabetes. It also captured the increasing burden 
(HRQOL deficit) associated with additional co-
morbidities in Nigerian diabetes patients as 
reported in several studies [17-19]. 
 
Effect of duration of diabetes indicates that 
diabetes imposes more burdens to the patients 
as individuals and reduces the country’s 
productivity profile as man-hour loss due 
diabetes is high. 
 
As the disease progresses to more severe 
situation, treatment option changes from diet to 
use of oral medication and/or insulin. This result 
is consistent with a study [15] which 
demonstrated that the longer the duration of 
diabetes, the higher chances of a patient 
developing overt nephropathy and other micro-
complications of diabetes which might require 
insulin treatment, thus, the HRQOL of the 
patients is lowered. 
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Overall utility score (HU13)  
aN=235-321 
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Overall utility Score and single attributes utility score (for all the respondents) 
 HUI3 single attributes   HUI2 single attributes 
 Mean SD   Mean SD 
Overall HUI3 0.4130 (0.0346)  Overall HUI2 
0.6122  (0.1878) 
Vision  0.8140 (0.0176)  Sensation 0.7706  (0.1597) 
Hearing 0.9304  (0.0139)  Mobility 0.8655  (0.1632) 
Speech 0.9730  (0.0060)  Emotion    0.7959  (0.0247) 
Ambulation 0.8265  (0.0211)  Cognition 0.8264  (0.1639) 
Dexterity 0.7858  (0.0231)  Self -care 0.8810  (0.0221) 
Emotion 0.8739  (0.0159)  Pain 0.7531  (0.0182) 
Cognition 0.7442  0.0229)  NA NA NA 
Pain and discomfort  0.6325  (0.0267)  NA NA NA 
aN varied depending on number of respondents with missing data for each patients’ characteristics in HUI2 and HUI3. NA= Not 
applicable to HUI2; ** p < 0.001  and *p <0.05 for comparison between Yes and No; bMean difference ≥ 0.03 and ≥ 0.05 for 
overall utility score and single attributes scores respectively are clinically significant.  
 
Limitations of the study 
 
The major limitations of this study were missing 
data, selection bias, and self-reported data. 
Missing data presented the most daunting 
challenge in demographic and clinical 
characteristics. Among the outcomes measured, 
utility scores were the most important. 
Fortunately, this measure did not suffer from 
missing data because the questionnaires were 
interviewer administered. Investigators’ bias was 
a potential limitation, though this was minimal as 
the investigators were trained before the study. 
Selection bias was a problem as participation 
was voluntary, though all the patients who were 
eligible and willing to participate were surveyed. 
It remains possible that patients who chose to 
participate in the study may have differed in 
some important ways from those who did not 
participate, which could affect the external 
validity or generalizability. Data were self-
reported, however, self-reported data about 
diabetes status have been established to be both 




Health Utility Index Mark 2 and Mark 3 were 
sufficiently sensitive and responsive to diabetes 
severity among Type 2 diabetes patients. These 
instruments can be used in clinical studies for a 
wide variety of conditions. HUI2 and HUI3 
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provide comprehensive, reliable, responsive and 
valid measures of health status and HRQL for 
subjects which can be compared across the 
countries. The widespread use of HUI facilitates 
the interpretation of results and permits 
comparisons of disease and treatment outcomes, 
and comparisons of long-term sequelae at the 
local, national and international levels. Utility 
scores of overall HRQL for patients are also used 
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